|
|
Previous Article | Table of Contents | Next Article 
Recombinant C5a stimulates transcription rather than translation of
interleukin-1 (IL-1) and tumor necrosis factor: translational signal
provided by lipopolysaccharide or IL-1 itself
R Schindler, JA Gelfand and CA Dinarello
Department of Medicine, Tufts University School of Medicine, Boston, MA.
We investigated the effects of recombinant C5a (rC5a) on gene expression
and synthesis of interleukin-1 beta (IL-1 beta) and tumor necrosis factor
(TNF) in fresh human peripheral blood mononuclear cells (PBMC). Total
(cell-associated and secreted) cytokine synthesis was measured. In the
strict absence of endotoxin (lipopolysaccharide [LPS]), rC5a resulted in a
small but statistically insignificant increase in immunoreactive IL-1 beta
and TNF, as well as in IL-1 and IL- 6 bioactivity. On the other hand, rC5a
induced marked transcriptional activation of IL-1 beta and TNF in a
dose-dependent fashion with an optimal concentration of 50 ng/mL. The
rC5a-induced cytokine messenger RNA (mRNA) was not spontaneously translated
into protein. At 50 ng/mL, rC5a induced the same levels of mRNA for IL-1
beta and TNF as 1 ng/mL of LPS, whereas LPS induced 12 times more IL-1 beta
protein and 70 times more TNF protein than rC5a alone. The C5a-induced mRNA
half-life was the same as that induced by LPS. Formyl-Meth-Leu-Phe (fMLP)
did not induce cytokine transcription. Pretreatment with rC5a enhanced
cytokine synthesis induced by other stimuli. After 2 hours of preincubation
with rC5a, PBMC synthesized 3 to 10 times more IL-1 beta and TNF on
subsequent stimulation by LPS or IL-1 itself. We conclude that rC5a
provides primarily a transcriptional but not translational signal for IL-1
beta and TNF; the half-life of the untranslated mRNA is the same as that of
translated message; rC5a-induced transcription upregulates PBMC for
enhanced synthesis of these cytokines; and a translational signal can be
provided by LPS or IL-1 itself.
Volume 76,
Issue 8,
pp. 1631-1638,
10/15/1990
Copyright © 1990 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. J. Welsh, A. N. Abbott, S.-A. Hwang, J. Indrigo, L. Y. Armitige, M. R. Blackburn, R. L. Hunter, and J. K. Actor
A role for tumour necrosis factor-{alpha}, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response
Microbiology,
June 1, 2008;
154(6):
1813 - 1824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Moulton, M. A. Mashruwala, A. K. Smith, D. R. Lindsey, R. A. Wetsel, D. L. Haviland, R. L. Hunter, and C. Jagannath
Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice
J. Leukoc. Biol.,
October 1, 2007;
82(4):
956 - 967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Markiewski and J. D. Lambris
The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight
Am. J. Pathol.,
September 1, 2007;
171(3):
715 - 727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Carta, S. Tassi, C. Semino, G. Fossati, P. Mascagni, C. A. Dinarello, and A. Rubartelli
Histone deacetylase inhibitors prevent exocytosis of interleukin-1beta-containing secretory lysosomes: role of microtubules
Blood,
September 1, 2006;
108(5):
1618 - 1626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Schindler, W. Beck, R. Deppisch, M. Aussieker, A. Wilde, H. Gohl, and U. Frei
Short Bacterial DNA Fragments: Detection in Dialysate and Induction of Cytokines
J. Am. Soc. Nephrol.,
December 1, 2004;
15(12):
3207 - 3214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-W. Park, C. Taube, C. Swasey, T. Kodama, A. Joetham, A. Balhorn, K. Takeda, N. Miyahara, C. B. Allen, A. Dakhama, et al.
Interleukin-1 Receptor Antagonist Attenuates Airway Hyperresponsiveness Following Exposure to Ozone
Am. J. Respir. Cell Mol. Biol.,
June 1, 2004;
30(6):
830 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Albrecht, A. M. Chinnaiyan, S. Varambally, C. Kumar-Sinha, T. R. Barrette, J. V. Sarma, and P. A. Ward
C5a-Induced Gene Expression in Human Umbilical Vein Endothelial Cells
Am. J. Pathol.,
March 1, 2004;
164(3):
849 - 859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Riedemann, R.-F. Guo, and P. A. Ward
A key role of C5a/C5aR activation for the development of sepsis
J. Leukoc. Biol.,
December 1, 2003;
74(6):
966 - 970.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Bao, M. Haas, D. M. Kraus, B. K. Hack, J. K. Rakstang, V. M. Holers, and R. J. Quigg
Administration of a Soluble Recombinant Complement C3 Inhibitor Protects Against Renal Disease in MRL/lpr Mice
J. Am. Soc. Nephrol.,
March 1, 2003;
14(3):
670 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Locati, U. Deuschle, M. L. Massardi, F. O. Martinez, M. Sironi, S. Sozzani, T. Bartfai, and A. Mantovani
Analysis of the Gene Expression Profile Activated by the CC Chemokine Ligand 5/RANTES and by Lipopolysaccharide in Human Monocytes
J. Immunol.,
April 1, 2002;
168(7):
3557 - 3562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lonnemann and K. M. Koch
{beta}2-Microglobulin Amyloidosis: Effects of Ultrapure Dialysate and Type of Dialyzer Membrane
J. Am. Soc. Nephrol.,
January 1, 2002;
13(90001):
S72 - 77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Ye
Regulation of nuclear factor {kappa}B activation by G-protein-coupled receptors
J. Leukoc. Biol.,
December 1, 2001;
70(6):
839 - 848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Shepard, M. Yang, P. Xie, D. D. Browning, T. Voyno-Yasenetskaya, T. Kozasa, and R. D. Ye
Constitutive Activation of NF-kappa B and Secretion of Interleukin-8 Induced by the G Protein-coupled Receptor of Kaposi's Sarcoma-associated Herpesvirus Involve Galpha 13 and RhoA
J. Biol. Chem.,
November 30, 2001;
276(49):
45979 - 45987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Canaud, V. Wizemann, F. Pizzarelli, R. Greenwood, G. Schultze, C. Weber, and D. Falkenhagen
Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy
Nephrol. Dial. Transplant.,
November 1, 2001;
16(11):
2181 - 2187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fung, P. G. Loubser, A. Undar, M. Mueller, C. Sun, W. N. Sun, W. K. Vaughn, and C. D. Fraser Jr
Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits
J. Thorac. Cardiovasc. Surg.,
July 1, 2001;
122(1):
113 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Hsu, M. Wang, D. D. Browning, N. Mukaida, and R. D. Ye
NF-{kappa}B Activation Is Required for C5a-Induced Interleukin-8 Gene Expression in Mononuclear Cells
Blood,
May 15, 1999;
93(10):
3241 - 3249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fayyazi, R. Sandau, L. Q. Duong, O. Gotze, H. J. Radzun, S. Schweyer, A. Soruri, and J. Zwirner
C5a Receptor and Interleukin-6 Are Expressed in Tissue Macrophages and Stimulated Keratinocytes but not in Pulmonary and Intestinal Epithelial Cells
Am. J. Pathol.,
February 1, 1999;
154(2):
495 - 501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Fischer, M. A. Jagels, and T. E. Hugli
Regulation of IL-6 Synthesis in Human Peripheral Blood Mononuclear Cells by C3a and C3adesArg
J. Immunol.,
January 1, 1999;
162(1):
453 - 459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sehic, S. Li, A. L. Ungar, and C. M. Blatteis
Complement reduction impairs the febrile response of guinea pigs to endotoxin
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 1998;
274(6):
R1594 - R1603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Perregaux, R. E. Laliberte, and C. A. Gabel
Human Monocyte Interleukin-1[BETA] Posttranslational Processing. EVIDENCE OF A VOLUME-REGULATED RESPONSE
J. Biol. Chem.,
November 22, 1996;
271(47):
29830 - 29838.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|